Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Glanbia's Sloan Ratio for the quarter that ended in Dec. 2025 was -3.07%.
As of Dec. 2025, Glanbia has a Sloan Ratio of -3.07%, indicating the company is in the safe zone and there is no funny business with accruals.
Glanbia (OTCPK:GLAPF) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2025, Glanbia has a Sloan Ratio of -3.07%, indicating the company is in the safe zone and there is no funny business with accruals.
Glanbia Sloan Ratio % Related Terms
Glanbia Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Glanbia's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Glanbia's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glanbia Sloan Ratio % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Glanbia's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Glanbia's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Glanbia's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Glanbia's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was 99.4 (Jun. 2025 ) + 83.9 (Dec. 2025 ) = $183 Mil.
Glanbia's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was 6.8 (Jun. 2025 ) + 361.7 (Dec. 2025 ) = $369 Mil.
Glanbia's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 was -47.7 (Jun. 2025 ) + -15.6 (Dec. 2025 ) = $-63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glanbia (GLAPF) has a Sloan Ratio % of -3.07% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Glanbia and its competitors.
Is Glanbia's Sloan Ratio % too high?
Glanbia's current Sloan Ratio % is -3.07%. Overall, Glanbia has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glanbia's Sloan Ratio % compare to KHC and GIS?
Glanbia's Sloan Ratio % of -3.07% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Consumer Packaged Goods company?
A good Sloan Ratio % depends on the Consumer Packaged Goods industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Glanbia and its competitors. Glanbia's current Sloan Ratio % is -3.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glanbia stock overvalued right now?
Based on GuruFocus' analysis, Glanbia (GLAPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.61, compared to a current price of $28.57 — trading 95.6% above its estimated fair value. The current Sloan Ratio % is -3.07%. Glanbia's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Glanbia (GLAPF), the current Sloan Ratio % is -3.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glanbia (GLAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Glanbia stock appears to be overvalued.
The current stock price of $28.57 is trading 95.6% above its estimated GF Value™ of $14.61.
GuruFocus considers Glanbia to be Significantly Overvalued.
Key valuation signals for GLAPF:
Sloan Ratio %: -3.07%
GF Value™: $14.61 vs. price of $28.57 (95.6% above fair value)
No single metric tells the full story. See the GLAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glanbia PLC is a ingredient and branded performance nutrition manufacturer company. Company offer an incredible breadth of expertise in nutrition. It works with food and beverage companies and sell the products across the globe . The company segments include Performance Nutrition (PN), Health & Nutrition (H&N) and Dairy Nutrition (DN). The company generates majority of the revenue from Performance Nutrition segment. Geographically, it has majority revenue from North America followed by Europe and Asia.
67GF Score
Get the complete analysis for GLAPF
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLAPF has been successfully added to your 
